$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Instructions for Imaavy (nipocalimab-aahu)
2026-02-01 22:25:32
Check Details
Analysis of the core efficacy and clinical therapeutic effects of entrectinib
2026-02-01 22:25:32
Check Details
Akatinib/Acalatinib-octuzumab provides superior PFS to chemotherapy in CLL
2026-02-01 22:25:32
Check Details
Ibrutinib/lenalidomide/rituximab produces long-term efficacy in reperfusion therapy of MCL
2026-02-01 22:25:32
Check Details
How long does it take for ruxolitinib tablets/ruxolitinib treatment to be effective?
2026-02-01 22:25:32
Check Details
What are the clinical effects and antibacterial and anti-inflammatory effects of clofazimine?
2026-02-01 22:25:32
Check Details
What are the precautions for Imaavy (nipocalimab-aahu)?
2026-02-01 22:25:32
Check Details
How many courses of treatment are needed with gosatuzumab/Todavir?
2026-02-01 22:25:32
Check Details
Subcutaneous evantumumab approved in multiple EGFR+ advanced NSCLC indications
2026-02-01 22:25:32
Check Details
Analysis of the main therapeutic effects and efficacy of enzalutamide/enzalutamide
2026-02-01 22:25:32
Check Details
Cost of one month of treatment with Sorafenib/Nexavar
2026-02-01 22:25:32
Check Details
How much does a course of pemetinib/pemetinib cost?
2026-02-01 22:25:32
Check Details
1
2
...
1547
1548
1549
1550
1551
1552
1553
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
2
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
3
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
4
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
5
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
6
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
7
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
8
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
9
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
10
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
11
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
12
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis